UDTR Global Radar

UDTR Global Rights of Nature Radar

Documentary registry of records detected across the scholarly, legal and institutional infrastructures monitored by UDTR.

A global documentary infrastructure designed to achieve the broadest verifiable and scientifically defensible coverage of the Rights of Nature.

← Back to Radar

Anti-SARS-CoV-2 Antibody Development over Four Years in Blood Donors

Identification

Public canonical key
radar:r-a74e2e0bb15a306ae3449aec83e43691
Authors
Christoph Niederhauser · Nadja Widmer · Caroline Tinguely · Franziska Suter‐Riniker · Stefano Fontana · Andreas S. Buser · Sophie Waldvogel · Jutta Thierbach · Max Züger · Peter Gowland
Reported year
2025
Reported language
en
Source type
article
First detected
2026-11-14T02:00:06.932552+00:00
Last metadata observation
2026-11-14T02:00:06.932552+00:00
Last HTTP verification
Not checked

Institutions reported by the source

University of Bern · Swiss Red Cross · Centre Hospitalier Universitaire Vaudois

Reported affiliation countries

CH

Documentary abstract — original language

The blood donor population has great potential to serve as a sentinel system for the general population. The data presented in this study of a survey of the seroprevalence of Anti-SARS-CoV-2 antibodies in Switzerland are an illustrative example of this possibility. From March 2020 to January 2021, the increase in antibody seroprevalence for both Anti-NCP and Anti-S was only very moderate, up to ~17%. In May/June 2021, the Anti-NCP seroprevalence was 21.6% and the S-seroprevalence 59.4%, respectively, indicating only a moderate natural infection rate. The Anti-seroprevalence rate was in good agreement with the first vaccination campaign launched in winter 2020/21. The dramatic increase in the antibodies against the NCP protein (74.6%) since November/December 2021 to June-August 2022 was simultaneous with the appearance and rapid spread of the Omicron SARS-CoV-2 variant in Switzerland and the abolition of compulsory mask wearing in public spaces. At the end of 2022, 99.0% of the blood donor population already developed antibodies against the S protein and 83.9% against the NCP. One year later, after the official termination of the pandemic, these seroprevalences were even higher, 99.8% for the Anti-S and 95.0% for Anti-NCP. This increase for both of them was in accordance with the vaccination campaigns, the abolition of mask wearing, and the spread of the Omicron variant. These data show how the blood donor population can be used to represent the infection surveillance of the general population of a region or country.

Identifiers

OPENALEX
https://openalex.org/W4414477166
DOI
10.3390/v17101292
PMID
https://pubmed.ncbi.nlm.nih.gov/41157564
PMCID
https://www.ncbi.nlm.nih.gov/pmc/articles/12567803

Documentary context

Documentary family
article
Source-reported types
article
Publishers
Multidisciplinary Digital Publishing Institute

Entity mentions are not evidence of legal recognition. Jurisdiction studied is separate from author affiliation country.

Sources

OpenAlex · Record 1

Cite this reference

Christoph Niederhauser; Nadja Widmer; Caroline Tinguely; Franziska Suter‐Riniker; Stefano Fontana; Andreas S. Buser; Sophie Waldvogel; Jutta Thierbach; Max Züger; Peter Gowland. Anti-SARS-CoV-2 Antibody Development over Four Years in Blood Donors. 2025. https://doi.org/10.3390/v17101292

JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·

APA, Chicago, ISO 690: bibliographic formats using available fields. OSCOLA / Bluebook: structured data only; full legal citation compliance is not claimed without verification of required elements.

APA
Christoph Niederhauser; Nadja Widmer; Caroline Tinguely; Franziska Suter‐Riniker; Stefano Fontana; Andreas S. Buser; Sophie Waldvogel; Jutta Thierbach; Max Züger; Peter Gowland. (2025). Anti-SARS-CoV-2 Antibody Development over Four Years in Blood Donors. https://doi.org/10.3390/v17101292
Chicago
Christoph Niederhauser; Nadja Widmer; Caroline Tinguely; Franziska Suter‐Riniker; Stefano Fontana; Andreas S. Buser; Sophie Waldvogel; Jutta Thierbach; Max Züger; Peter Gowland. Anti-SARS-CoV-2 Antibody Development over Four Years in Blood Donors. 2025. https://doi.org/10.3390/v17101292
ISO 690
Christoph Niederhauser; Nadja Widmer; Caroline Tinguely; Franziska Suter‐Riniker; Stefano Fontana; Andreas S. Buser; Sophie Waldvogel; Jutta Thierbach; Max Züger; Peter Gowland. Anti-SARS-CoV-2 Antibody Development over Four Years in Blood Donors. 2025. https://doi.org/10.3390/v17101292

Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31

UDTR Global Rights of Nature Legal Library. Anti-SARS-CoV-2 Antibody Development over Four Years in Blood Donors. Documentary record: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-a74e2e0bb15a306ae3449aec83e43691/ · Last HTTP verification: not performed

Report a correction

Frozen-version metadata

Research dossiers and documentary relations

Source roles

Bibliographic / original publication source · https://doi.org/10.3390/v17101292

An authority link alone does not verify a legal claim. Abstracts and full texts remain subject to their source terms.

Documentary status

Relevance pending

Library

This identity is not yet included in the Legal Library.

UDTR Global Rights of Nature Legal Library